Even C, Wang HM, Li SH, Ngan RK, et al. Phase II, Randomized Study of Spartalizumab (PDR001), an Anti-PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer. Clin Cancer Res 2021;27:6413-6423.
PMID: 34433653